A single unblinded RCT of only 35 subjects of oral prednisolone vs no treatment demonstrated non-significant superiority of corticosteroid therapy considering global group changes in Neuropathy Impairment Scores (NIS), with borderline significant superiority, but only considering numbers of improved subjects excluding patients having not completed the study, but not with an intention-to-treat analysis. 51 A few studies have shown equivalence of corticosteroids to intravenous immunoglobulins, themselves of RCT-proven benefit in CIDP, as discussed elsewhere in this paper.
← all excerpts
Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Current Therapeutic Approaches and Future Outlooks.
1
—
—